Identification of candidate reference chemicals for in vitro steroidogenesis assays

Pinto, Caroline Lucia; Markey, Kristan; Dix, David; Browne, Patience

doi:10.1016/j.tiv.2017.11.003

Title: Identification of candidate reference chemicals for in vitro steroidogenesis assays

Full Record
Other Related Research

Authors:: Pinto, Caroline Lucia; Markey, Kristan; Dix, David; Browne, Patience

Publication Date:: 2018-03-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1549052

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Toxicology in Vitro

Additional Journal Information:: Journal Name: Toxicology in Vitro Journal Volume: 47 Journal Issue: C; Journal ID: ISSN 0887-2333

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Pinto, Caroline Lucia, Markey, Kristan, Dix, David, and Browne, Patience. Identification of candidate reference chemicals for in vitro steroidogenesis assays.  United Kingdom: N. p., 2018. 
Web.  doi:10.1016/j.tiv.2017.11.003.

Copy to clipboard


                    Pinto, Caroline Lucia, Markey, Kristan, Dix, David, & Browne, Patience. Identification of candidate reference chemicals for in vitro steroidogenesis assays.  United Kingdom.  https://doi.org/10.1016/j.tiv.2017.11.003

Copy to clipboard


                    Pinto, Caroline Lucia, Markey, Kristan, Dix, David, and Browne, Patience. Thu .  
"Identification of candidate reference chemicals for in vitro steroidogenesis assays".  United Kingdom.  https://doi.org/10.1016/j.tiv.2017.11.003.

Copy to clipboard


                    
@article{osti_1549052,

  title        = {Identification of candidate reference chemicals for in vitro steroidogenesis assays},

  author       = {Pinto, Caroline Lucia and Markey, Kristan and Dix, David and Browne, Patience},

  abstractNote = {},

  doi          = {10.1016/j.tiv.2017.11.003},

  journal      = {Toxicology in Vitro},

  number       = C,

  volume       = 47,

  place        = {United Kingdom},

  year         = {2018},

  month        = {3}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.tiv.2017.11.003

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 8 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Multiple animal studies for medical chemical defense program in soldier/patient decontamination and drug development on task 88-36: Development of in vitro screening assays for candidate pretreatment and treatment compounds. Final report, 1 July 1988-1 July 1989

Technical Report Joiner, R ; Dill, G ; Hobson, D ; ...

A task was instituted at the Medical Research and Evaluation Facility (MREF) to develop in vitro assays to screen pretreatment and treatment compounds for their ability to protect or reverse the toxic effects of organophosphates and vesicants. Four vesicant assays and three nerve agent assays were developed. Two of the vesicant assays were for cell viability of keratinocyte, one in the presence of distilled mustard and one lewisite. One assay determines the effect of vesicants on keratinocyte reproduction and the other the effect of distilled mustard on cellular coenzyme nicotinamide adenine dinucleotide content. The organophosphate assays measure the effects onmore »« less
In vitro evaluation of candidate pretreatment and treatment compounds against sulfur mustard (HD) -induced human mononuclear leukocyte toxicity using a dye exclusion cell viability assay

Technical Report Starner, R A ; Blank, J A ; Hobson, D W ; ...

An assay measuring propidium iodide (PI) incorporation into nonviable human peripheral blood mononuclear leukocytes (PBML) was established at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), and the technology transferred and implemented at Battelle's Medical Research and Evaluation Facility (MREF) for use as a screen to evaluate candidate compounds for direct cytotoxicity as well as for efficacy in preventing HD-induced cytotoxicity. For assay transition, studies were performed to establish a fixed HD challenge concentration; to develop a positive and negative control dataset; and to establish the reproducibility in obtaining an EC50 (concentration of candidate compound required to providemore »« less
IN VIVO AND IN VITRO ASSAYS WITH $sup 59$Fe IN GALLUS DOMESTICUS WITH REFERENCE TO THE TRANSPORT OF IRON IN SERUM (in Spanish)

Journal Article Martin-Mateo, M C ; Sebastian, M F ; Planas, J - Rev. Espan. Fisiol.
Identification and Mechanistic Understanding of Dihydroorotate Dehydrogenase Point Mutations in Plasmodium falciparum that Confer in Vitro Resistance to the Clinical Candidate DSM265

Journal Article White, John ; Dhingra, Satish K. ; Deng, Xiaoyi ; ... - ACS Infectious Diseases

Malaria is one of the most challenging human infectious diseases, and both prevention and control have been hindered by the development of Plasmodium falciparum resistance to existing therapies. Several new compounds with novel mechanisms are in clinical development for the treatment of malaria, including DSM265, an inhibitor of Plasmodium dihydroorotate dehydrogenase. To explore the mechanisms by which resistance might develop to DSM265 in the field, we selected for DSM265-resistant P. falciparum parasites in vitro. Any of five different amino acid changes led to reduced efficacy on the parasite and to decreased DSM265 binding to P. falciparum DHODH. The DSM265-resistant parasitesmore »« less
Cited by 19
https://doi.org/10.1021/acsinfecdis.8b00211

Full Text Available
Identification and ranking of poly (ADP-ribose) polymerase inhibitors as protectors against sulfur mustard induced decrease in cellular energy and viability in in vitro assays with human lymphocytes

Technical Report Meier, H L ; Kelly, S A

Lymphocyte were utilized as a model for investigating HD effects on resting cells. Lymphocytes exposed to HD demonstrated a concentration dependent decrease in ATP, NAD, and viability. The decrease began in 15 minutes for ATP, 2 hours for NAD, and 6 hours for viability. All three of these HD initiated biochemical changes can be blocked by poly (ADP-ribose) polymerase inhibitors (PADPRPI). To completely inhibit HD initiated ATP, NAD, and viability decreases the PADPRPI had to be present at time 0, 1, and 4 hours respectfully. The amount of protection conferred by the PADPRPI in the viability assay decreased in amore »« less

Similar Records